Identification of SV40 T-antigen mutants that alter T-antigen-induced chromosome damage in human fibroblasts.
The SV40 T antigen causes numerical (aneuploidy) and structural (aberrations) chromosome damage when expressed in human diploid fibroblasts. This chromosome damage precedes the acquisition of neoplastic traits such as anchorage independence, colony formation in reduced serum growth factors, immortalization, or tumorigenicity. Therefore, chromosome damage may be important in acquiring these traits because it could provide a mutational mechanism. To determine how the T antigen causes chromosome damage, point mutations were constructed that altered previously defined biochemical functions of the T protein. Mutant T antigen constructs were introduced into human diploid fibroblasts and selected by using G418. Clones of G418r cells that expressed mutant T antigens were expanded and scored for chromosome damage. Most of these mutant T antigens caused [corrected] levels of chromosome damage similar to those caused by [corrected] the wild-type T antigen. However, some T-antigen mutants induced fewer chromosome changes. A subset of these clones that induced less chromosome damage than wild-type T were examined further. Mutant T-antigen protein levels from this subset were quantified with flow cytometry and compared with wild-type protein expression levels. Mutations of T antigen shown previously to form less stable complexes with p53 caused less chromosome damage. A mutation in the zinc finger domain of T antigen also caused less chromosome damage. Interestingly, a mutant that caused loss of the ATPase activity of T antigen caused an increase in endoreduplicated cells. Also, a correlation was noted between cells expressing very low levels of T antigen (below detection limits when using flow cytometry) and an undamaged karyotype. This correlation indicates that there is a threshold level of T-antigen expression that induces chromosome damage and that expression levels on a per-cell basis rather than on a population basis should be considered in subsequent studies.
Ray
F A
FA
Life Sciences Division, Los Alamos National Laboratory, New Mexico. andrewvray@ccgateway.amc.edu
Waltman
M J
MJ
Lehman
J M
JM
Little
J B
JB
Nickoloff
J A
JA
Kraemer
P M
PM
D019943:Amino Acid Substitution; D000782:Aneuploidy; D000952:Antigens, Polyomavirus Transforming / Q000235:genetics* / Q000378:metabolism; D002869:Chromosome Aberrations; D002999:Clone Cells; D005434:Flow Cytometry; D015870:Gene Expression; D005814:Genes, Viral; D006801:Humans; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D010641:Phenotype; D011485:Protein Binding; D013539:Simian virus 40 / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity; D014162:Transfection; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D000952:Antigens, Polyomavirus Transforming; D016159:Tumor Suppressor Protein p53